| 000 | 01621 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250515232017.0 | ||
| 264 | 0 | _c20101220 | |
| 008 | 201012s 0 0 eng d | ||
| 022 | _a1778-3585 | ||
| 024 | 7 |
_a10.1016/S0924-9338(10)71702-8 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDe Hert, M | |
| 245 | 0 | 0 |
_aPhysical health management in psychiatric settings. _h[electronic resource] |
| 260 |
_bEuropean psychiatry : the journal of the Association of European Psychiatrists _cJun 2010 |
||
| 300 |
_aS22-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 |
_aAntipsychotic Agents _xadverse effects |
| 650 | 0 | 4 |
_aCardiovascular Diseases _xchemically induced |
| 650 | 0 | 4 | _aComorbidity |
| 650 | 0 | 4 | _aCooperative Behavior |
| 650 | 0 | 4 | _aCross-Sectional Studies |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xchemically induced |
| 650 | 0 | 4 | _aDrug Monitoring |
| 650 | 0 | 4 | _aHealth Status Indicators |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInterdisciplinary Communication |
| 650 | 0 | 4 | _aMass Screening |
| 650 | 0 | 4 |
_aMetabolic Syndrome _xchemically induced |
| 650 | 0 | 4 | _aPatient Care Team |
| 650 | 0 | 4 |
_aPsychotic Disorders _xdrug therapy |
| 650 | 0 | 4 |
_aReferral and Consultation _xstatistics & numerical data |
| 700 | 1 | _avan Winkel, R | |
| 700 | 1 | _aSilic, A | |
| 700 | 1 | _aVan Eyck, D | |
| 700 | 1 | _aPeuskens, J | |
| 773 | 0 |
_tEuropean psychiatry : the journal of the Association of European Psychiatrists _gvol. 25 Suppl 2 _gp. S22-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/S0924-9338(10)71702-8 _zAvailable from publisher's website |
| 999 |
_c19964118 _d19964118 |
||